Status:
RECRUITING
Loss of Y Chromosome in Aortic Stenosis
Lead Sponsor:
University of Virginia
Conditions:
Aortic Stenosis
Eligibility:
MALE
40+ years
Brief Summary
The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in ...
Eligibility Criteria
Inclusion
- Aortic stenosis (valve area \<1.5cm2)
Exclusion
- Bicuspid aortic valve
- History of radiation to chest
- Inflammatory (autoimmune, rheumatologic) disease associated with aortic stenosis
- Active cancer
Key Trial Info
Start Date :
August 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06595407
Start Date
August 15 2024
End Date
June 1 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22903